share_log

Insider Purchase: Director at $ATEX (ATEX) Buys 2,000 Shares

Insider Purchase: Director at $ATEX (ATEX) Buys 2,000 Shares

內部交易:$ATEX(ATEX)的董事購買了2,000股
Quiver Quantitative ·  11/22 17:17

LESLIE B DANIELS, a director at $ATEX ($ATEX), bought 2,000 shares of the company on 11-20-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings by approximately inf%. Following this trade, they now own 2,000 shares of $ATEX stock.

$ATEX Insider Trading Activity

$ATEX insiders have traded $ATEX stock on the open market 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here's a breakdown of recent trading of $ATEX stock by insiders over the last 6 months:

  • LESLIE B DANIELS purchased 2,000 shares.
  • GENA L ASHE (Chief Legal Officer & Corp Sec) sold 5,547 shares.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ATEX Hedge Fund Activity

We have seen 68 institutional investors add shares of $ATEX stock to their portfolio, and 55 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • D. E. SHAW & CO., INC. added 197,970 shares (+254.2%) to their portfolio in Q3 2024
  • VANGUARD GROUP INC added 161,597 shares (+19.3%) to their portfolio in Q3 2024
  • QUBE RESEARCH & TECHNOLOGIES LTD added 155,222 shares (+3990.3%) to their portfolio in Q3 2024
  • BLACKROCK, INC. removed 114,646 shares (-10.3%) from their portfolio in Q3 2024
  • STONEHILL CAPITAL MANAGEMENT LLC removed 114,553 shares (-16.3%) from their portfolio in Q3 2024
  • NUVEEN ASSET MANAGEMENT, LLC added 112,696 shares (+330.4%) to their portfolio in Q3 2024
  • FMR LLC added 108,683 shares (+76.4%) to their portfolio in Q3 2024

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.


This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論